Frequency of HCV seropositivity in lichen planus
Keywords:
Lichen planus, HCV seropositivityAbstract
Objective To determine the frequency of Hepatitis C (HCV) seropositivity in patients of lichen planus (LP). Methods This observational cross-sectional study was conducted over a period of 6 months, at Dermatology Department PNS Shifa hospital Karachi. Eighty-two (n=82) patients with a diagnosis of LP fulfilling the inclusion and exclusion criteria were enrolled using non-probability consecutive sampling technique. Detailed history, physical examination and biochemical measurements were recorded. Outcome variable i.e. HCV seropositivity was determined in laboratory with third generation ELISA technique. All data were entered and analyzed using SPSS Version 20.0. Results The mean age of study population was 39.32±13.212 years. On analysis of demographics data it was observed that 25 (30.5%) were below 30 years of age and 57 (69.5%) were of age 30 years and above. 39 (47.6%) were males and 43 (52.4%) were females. On analysis of frequency of outcome variable, 15 patients (18.3%) were HCV positive out of 82 patients irrespective of gender, morphological pattern and site of disease. Conclusion HCV positivity is common in patients with lichen planus in Pakistani population. Age, gender, morphological pattern and site of involvement have no effect of HCV positivity.References
Lodi G, Pellicano R, Carrozzo M. Hepatitis C virus infection and lichen planus: a systematic review with meta-analysis. Oral Dis. 2010;16:601-12.
Nagao Y, Sata M. A retrospective case-control study of hepatitis C virus infection and oral lichen planus in Japan: association study with mutations in the core and NS5A region of hepatitis C virus. BMC Gastroenterol.2012;12:31.
Ukonu AB, Augustine U. The prevalence of hepatitis C Virus (HCV) among lichen planus patients and its clinical pattern at the University of Abuja Teaching Hospital, Gwagwalada, Abuja, Nigeria. Glob J Health Sci.2012;4(5):113-9.
Konidena A, Pavani BV. Hepatitis C virus infection in patients with oral lichen planus. Niger J Clin Pract. 2011;14:228-31.
Gupta S, Jawanda MK. Oral lichen planus: An update on etiology, pathogenesis, clinical presentation, diagnosis and management. Indian J Dermatol. 2015;60:222-9.
Yamamoto T, Nakane T, Osaki T. The mechanism of mononuclear cell infiltration in oral lichen planus: the role of cytokines released from keratinocytes. J Clin Immunol. 2000;20:294-305.
Deguchi M, Aiba S, Ohtani H, Nagura H, Tagami H. Comparison of the distribution and numbers of antigen‐presenting cells among T‐lymphocyte‐mediated dermatoses: CD1a+, factor XIIIa+, and CD68+ cells in eczematous dermatitis, psoriasis, lichen planus and graft‐versus‐host disease. Arch Dermatol Res. 2002;294:297-302.
Musso T, Scutera S, Vermi W, Daniele R, Fornaro M, Castagnoli C et al. Activin A induces Langerhans cell differentiation in vitro and in human skin explants. PLOS One. 2008;3(9):e327137.
Zhou XJ, Sugerman PB, Savage NW, Walsh LJ, Seymour GJ. Intra‐epithelial CD8+ T cells and basement membrane disruption in oral lichen planus. J Oral Pathol Med. 2002;31(1):23-7.
Zhou XJ, Sugerman PB, Savage NW, Walsh LJ. Matrix metalloproteinases and their inhibitors in oral lichen planus. J Cutan Pathol. 2001;28(2):72-82
Ammar M, Mokni M, Boubaker S, El Gaied A, Ben Osman A, Louzir H. Involvement of granzyme B and granulysin in the cytotoxic response in lichen planus. J Cutan Pathol. 2008;35:630-4.
Abell E, Presbury DG, Marks R, Ramnarain D. The diagnostic significance of immunoglobulin and fibrin deposition in lichen planus. Br J Dermatol. 1975;93:17-24.
Kulthanan K, Jiamton S, Varothai S, Pinkaew S, Sutthipinittharm P. Direct immunofluorescence study in patients with lichen planus. Int J Dermatol. 2007;46:1237–41.
Issa MCA, Gaspar AP, Gaspar NK. Líquen plano e hepatite C. An Bras Dermatol. 1999;75:459-63.
Van der Meij EH, Van der Waal I. Hepatitis C virus infection and oral lichen planus: a report from the Netherlands. J Oral Pathol Med. 2000;29:255-8.
Tucker SC, Coulson IH. Lichen planus is not associated with hepatitis C virus infection in patients from North West England. Acta Derm Venereol. 1999;79:378-9.
Ghodsi SZ, Daneshpazhooh M, Shani M, Nikfarjam A. Lichen planus and hepatitis C: a case-control study. BMC Dermatol. 2004;4:6.
Ingafou M, Porter SR, Scully C, Teo CG. No evidence of HCV infection or liver disease in British patients with local lichen planus. Int J Oral Maxillofac Surg. 1998;27:65-6.
Gruppo Italiano Studi Epidemiologic In Dermatologia (GISED). Lichen planus and liver disease: a multicenter case-control study. Br Med J. 1990;300:227-30.
Figueiredo LC, Carrilho FJ, Andrage HF, Milgliari DA. Oral lichen planus and hepatitis C virus infection. Oral Dis. 2002;8:42-6.
Carozzo M, Francia Di Celle P, Gandolfo S, Carbone M, Conrotto D, Fasano ME. Increased frequency of HLA-DR6 allele in Italian patients with hepatitis C virus-associated lichen planus. Br J Dermatol. 2001;144:803-8.
Lunel F, Cacoub P. Treatment of autoimmune and extra hepatic manifestations of hepatitis C virus infection. J Hepatol.1999;31:210-6.
Nagao Y, Sata M, Suzuki H, Kameyama T, Ueno T. Histological Improvement of oral lichen planus in patients with chronic hepatitis C treated with Interferon. Gastroenterology. 1999;177:283-4.
